$230 Million

Cue Health, Inc.

Initial Public Offering

Bookrunner, September 2021

Cue Health Inc. (“Cue Health” or the “Company”) is a health technology company that has developed a platform consisting of the following hardware and software components: (1) the Cue Health Monitoring System, made up of a portable, durable and reusable reader, a single-use test cartridge, and a sample collection wand, (2) the Cue Data and Innovation Layer, with cloud-based data and analytics capability, (3) the Cue Virtual Care Delivery Apps, including the Cue Health App and the  Cue Enterprise Dashboard, and (4) the Cue Ecosystem Integrations and Apps, which allow for integrations with third-party applications and sensors.  The Company’s first commercially available diagnostic test is a COVID-19 Test Kit and the Company has five additional Test Kits in late-stage technical development for flu, RSV, fertility, pregnancy and inflammation.  Through Cue Health’s connected diagnostic solution, the Company seeks to enable the shift of care to virtual settings, while also connecting the physical care paradigm to the new digital ecosystem.

More Like This

Nov 2021
$116.3 Million

Initial Public Offering

Bookrunner

View Details
Nov 2021
$500.3 Million

Initial Public Offering

Bookrunner

View Details
Oct 2021
$86.9 Million

Initial Public Offering

Lead Left Bookrunner

View Details